Rare pathogenic variants in WNK3 cause X-linked intellectual disability.
暂无分享,去创建一个
R. Redon | J. Rosenfeld | D. Grozeva | S. Antonarakis | R. Stevenson | C. Schwartz | S. Milla | A. Toutain | F. Martínez | R. Louie | M. Cobb | S. Küry | S. Robert | M. Friez | E. Seaby | B. Gilbert-Dussardier | S. Haider | L. Pasquier | E. Colin | D. Bonneau | B. Cogné | F. L. Raymond | Xue Zeng | S. Mercier | K. Õunap | K. Kahle | M. V. van Slegtenhorst | P. Ilves | W. Deb | B. Isidor | Wendy K. Chung | Arjan Bouman | L. Hao | K. Retterer | S. Bézieau | V. Vignard | P. Boisseau | Adam J. Kundishora | S. Odent | M. Rio | T. Besnard | K. Stouffs | S. Schmitt | K. Monaghan | S. Coury | I. Wentzensen | B. Keren | P. Charles | M. Vincent | P. Lindenbaum | Lindsay E. Rhodes | Shreyas Panchagnula | Emre Kiziltug | Phan Q. Duy | Jinwei Zhang | Anne-Sophie Denommé-Pichon | F. Rajabi | E. Scalais | K. McWalter | Helena Perez-Pena | Y. van Bever | A. Jaykumar | E. Brischoux-Boucher | Flora Bréhéret | E. Ranza | X. Blanc | E. Torti | S. S. Josiah | S. Audebert-Bellanger | Hong Li | A. Caro-Llopis | K. Reinson | E. Barr | Solveig Heide Guihard | A. Wilson | D. Quinquis | Elaine M. Pereira | S. Berger | X. Le Guillou | Syed Raza Akhtar Rizvi | Wallid Deb | E. Kiziltug | S. Audebert‐Bellanger | E. Pereira | Farrah Rajabi | A. Denommé-Pichon
[1] B. Tang,et al. WNK3 Maintains the GABAergic Inhibitory Tone, Synaptic Excitation and Neuronal Excitability via Regulation of KCC2 Cotransporter in Mature Neurons , 2021, Frontiers in Molecular Neuroscience.
[2] B. Molyneaux,et al. Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a , 2020, Nature Communications.
[3] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[4] R. Lifton,et al. Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival , 2019, Science Signaling.
[5] K. H. Jeong,et al. Increased expression of WNK3 in dispersed granule cells in hippocampal sclerosis of mesial temporal lobe epilepsy patients , 2018, Epilepsy Research.
[6] J. Poncer,et al. GABAA receptor dependent synaptic inhibition rapidly tunes KCC2 activity via the Cl−-sensitive WNK1 kinase , 2017, Nature Communications.
[7] Alaina P. Vidmar,et al. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients. , 2017, Bone.
[8] D. Ellison,et al. WNK Kinase Signaling in Ion Homeostasis and Human Disease. , 2017, Cell metabolism.
[9] S. Elledge,et al. Functional kinomics establishes a critical node of volume-sensitive cation-Cl− cotransporter regulation in the mammalian brain , 2016, Scientific Reports.
[10] M. Hegde,et al. Peripheral motor neuropathy is associated with defective kinase regulation of the KCC3 cotransporter , 2016, Science Signaling.
[11] F. Gage,et al. KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome , 2016, Proceedings of the National Academy of Sciences.
[12] D. Valle,et al. GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.
[13] Alessandra Renieri,et al. Targeted Next‐Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability , 2015, Human mutation.
[14] I. Scheffer,et al. Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures , 2015, Nature Communications.
[15] K. Shokat,et al. WNK1-regulated inhibitory phosphorylation of the KCC2 cotransporter maintains the depolarizing action of GABA in immature neurons , 2015, Science Signaling.
[16] J. A. Payne,et al. Cation-chloride cotransporters in neuronal development, plasticity and disease , 2014, Nature Reviews Neuroscience.
[17] D. Alessi,et al. The WNK-SPAK/OSR1 pathway: Master regulator of cation-chloride cotransporters , 2014, Science Signaling.
[18] Giada Cellot,et al. GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders , 2014, Front. Pediatr..
[19] Gabriele Deidda,et al. Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives , 2014, Front. Cell. Neurosci..
[20] A. Contractor,et al. The Developmental Switch in GABA Polarity Is Delayed in Fragile X Mice , 2014, The Journal of Neuroscience.
[21] D. Alessi,et al. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+–Cl− co-transporters , 2014, The Biochemical journal.
[22] Xiaojun Ding,et al. Protein kinase WNK3 regulates the neuronal splicing factor Fox-1 , 2012, Proceedings of the National Academy of Sciences.
[23] Kristopher T Kahle,et al. The GABA Excitatory/Inhibitory Shift in Brain Maturation and Neurological Disorders , 2012, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[24] J. Kleinman,et al. Spatiotemporal transcriptome of the human brain , 2011, Nature.
[25] J L Rapoport,et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia , 2011, Molecular Psychiatry.
[26] D. Arion,et al. Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia. , 2011, Archives of general psychiatry.
[27] R. Lifton,et al. Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases. , 2010, Biochimica et biophysica acta.
[28] Ji-Bin Peng,et al. WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway. , 2008, American journal of physiology. Renal physiology.
[29] E. Rajcan-Separovic,et al. Autism‐associated familial microdeletion of Xp11.22 , 2008, Clinical genetics.
[30] Nicholas C. Spitzer,et al. Electrical activity in early neuronal development , 2006, Nature.
[31] D. Alessi,et al. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. , 2006, The Biochemical journal.
[32] Jesse Rinehart,et al. WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Jensen,et al. NKCC1 transporter facilitates seizures in the developing brain , 2005, Nature Medicine.
[34] M. Hayden,et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. , 2004, American journal of human genetics.
[35] G. Giebisch,et al. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion , 2003, Nature Genetics.
[36] E. Delpire,et al. Cation Chloride Cotransporters Interact with the Stress-related Kinases Ste20-related Proline-Alanine-rich Kinase (SPAK) and Oxidative Stress Response 1 (OSR1)* , 2002, The Journal of Biological Chemistry.
[37] J. A. Payne,et al. The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation , 1999, Nature.
[38] E. Delpire,et al. Expression of the Na-K-2Cl cotransporter is developmentally regulated in postnatal rat brains: a possible mechanism underlying GABA's excitatory role in immature brain. , 1997, Journal of neurobiology.
[39] F. Martínez,et al. Letter to the editor: Refined localization of the Prieto‐Syndrome locus , 1996 .
[40] F. Mulas,et al. X‐linked dysmorphic syndrome with mental retardation , 1987, Clinical genetics.